Want to see IN:BAFNAPH full AI Analyst Report?
Bafna Pharmaceuticals Limited (BAFNAPH) Income Statement
Bafna Pharmaceuticals Limited Income Statement
Last quarter (Q1 2027), Bafna Pharmaceuticals Limited's total revenue was $284.94M, a decrease of 17.70% from the same quarter last year. In Q1, Bafna Pharmaceuticals Limited's net income was $751.00K. See Bafna Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 1.51B | $ 1.46B | $ 1.52B | $ 1.15B | $ 851.40M | |
| $ 201.42M | $ 168.77M | $ 452.15M | $ 175.56M | $ 137.18M | |
| $ 102.67M | $ 105.89M | $ 214.49M | $ 71.63M | $ 272.51M | |
| Depreciation and Amortization | $ 60.73M | $ 48.90M | $ 49.95M | $ 53.34M | $ 54.93M |
| $ 207.04M | $ 117.73M | $ 146.34M | $ 189.88M | $ 112.34M | |
| $ 98.75M | $ 62.87M | $ 63.51M | $ 103.92M | $ 64.98M | |
| $ 10.95M | $ -21.35M | $ -164.18M | $ 12.24M | $ -12.82M | |
| $ 109.70M | $ 41.52M | $ 73.48M | $ 116.16M | $ 52.16M | |
| $ 111.00M | $ 41.52M | $ 73.48M | $ 113.38M | $ 52.16M | |
| Per Share Metrics | |||||
| Basic EPS | $ 4.69 | $ 1.76 | $ 3.11 | $ 4.79 | $ 2.21 |
| Diluted EPS | $ 4.69 | $ 1.76 | $ 3.11 | $ 4.79 | $ 2.21 |
| Weighted Average Shares Outstanding | 23.67M | 23.69M | 23.63M | 23.66M | 23.66M |
| Weighted Average Shares Outstanding (Diluted) | 23.67M | 23.69M | 23.66M | 23.66M | 23.66M |
Currency in INR